European Archives - Page 806 of 821 - European Medical Journal

Continue
EMJ
2 Mins
8th April 2014

Caffeine against Alzheimer’s Disease

As part of a German-French research project, a team led by Dr. Christa E. Müller from the University of Bonn and Dr. David Blum from the…
EMJ
2 Mins
1st April 2014

Adverse Events

A year after I graduated, I was working in an emergency department when one of my colleagues killed someone.
EMJ
4 Mins
30th March 2014

Analysis of EUROMAX and HORIZONS-AMI Trials of the Medicines Company’s Angiomax(R) (Bivalirudin) Presented at ACC.14

Analysis of EUROMAX and HORIZONS-AMI Trials of the Medicines Company’s Angiomax(R) (Bivalirudin) Presented at ACC.14
EMJ
3 Mins
27th March 2014

Yogurt in Nutrition Initiative Welcomes the Expertise of the International Osteoporosis Foundation as It Highlights the Role of Dairy Products on Bone Health

The importance of dairy products, including yogurt, to bone health has been recognised again today with the announcement of a new collaboration between…
EMJ
2 Mins
27th March 2014

Norgine and Innovacell Dose First Patient in Phase IIb Clinical Trial of ICEF15, a Personalised Cell Therapy to Treat Faecal Incontinence

Norgine B.V. (“Norgine”) and Innovacell today announced that the first patient has been dosed in the Phase IIb STEFFI study, which has been designed to…
EMJ
1 Mins
14th March 2014

‘Early Access’ Scheme Unveiled for Innovative Medicines

People with advanced cancer and other serious illnesses like dementia could soon benefit from early access to innovative and promising treatments.
EMJ
4 Mins
21st February 2014

NICE Consults on Draft Guidance Recommending New Drug for Type 2 Diabetes

NICE, the health and social care guidance body, is currently appraising canagliflozin (Invokana, Janssen-Cilag) when used in combination with…
EMJ
21st February 2014

Novel Anticoagulants in Atrial Fibrillation

This educational seminar, supported by an independent educational grant from Daiichi Sankyo, was held at the AHA congress in Dallas on 19th November 2013.
EMJ
21st February 2014

Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation – (Engage Af – Timi 48 Trial): Primary Results

The following is an executive summary of the abstract presentation by Prof Robert Giugliano on the ENGAGE AF – TIMI 48 trial primary results.
EMJ
February 2014

EMJ Cardiology 2 [Suppl 1] 2014

The mission of the American Heart Association (AHA) is ” Building healthier lives, free of cardiovascular disease and stroke. That single purpose drives…”